Design of a novel type IV lipid-based delivery system for improved delivery of drugs with low partition coefficient

Journal of Liposome Research
Laxmi NarayanaNalini R Shastri

Abstract

The physicochemical properties of drugs such as partition coefficient play a major role in the development of lipid-based drug delivery systems. The major obstacle lies in encapsulation of a drug with low partition coefficient into these systems. The objective of this study was to design and optimize a novel lipid-based delivery system with higher loading, improved pharmacokinetics consequently enhancing the oral bioavailability of drugs with low partition coefficient like valsartan. The optimized formulation consists of Capryol 90, Cremophor RH 40, and Transcutol HP. Pseudo ternary phase diagrams were used to optimize the components and their concentrations in the formulation. Dissolution studies of the selected formulations were compared with plain drug and marketed product at three pH conditions (pH 1.2, 4.5 and 6.8). Pharmacokinetic parameters of optimized formulations were determined in Wistar rats and compared with that of plain drug. The optimized formulation with a mean particle size of 50 nm showed significant improvement (p < 0.05) in dissolution rate with pH independence compared to plain drug and marketed product. The in vivo studies in Wistar rats revealed about 2.30- and 1.68-fold increase in the oral bioavailabil...Continue Reading

References

Sep 18, 1998·International Journal of Cardiology·V P MazayevD O Spormann
Mar 4, 2000·Lancet·M Burnier, H R Brunner
Jun 7, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·C Leuner, J Dressman
Oct 18, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·C W Pouton
Jan 29, 2003·International Journal of Pharmaceutics·Venkatramana M RaoYihong Qiu
May 7, 2003·Clinical Pharmacology and Therapeutics·Yorki TayrouzGerd Mikus
Oct 14, 2005·Drug Development and Industrial Pharmacy·Lanlan WeiWeisan Pan
Jul 4, 2006·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Colin W Pouton
Aug 31, 2007·Drug Development and Industrial Pharmacy·Subrata MallickPintu K De
Dec 25, 2007·Advanced Drug Delivery Reviews·Christopher J H PorterWilliam N Charman
Feb 26, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Flemming Seier NielsenAnette Müllertz
Jul 29, 2009·International Journal of Pharmaceutics·Yosra S R ElnaggarOssama Y Abdallah
Sep 29, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Thao Do ThiGuy Van den Mooter
Feb 9, 2010·Critical Reviews in Therapeutic Drug Carrier Systems·Bhupinder SinghO Katare
Feb 26, 2010·AAPS PharmSciTech·Adhvait R DixitSamir G Patel
Apr 9, 2010·Indian Journal of Pharmaceutical Sciences·G Ahuja, K Pathak
Aug 31, 2010·Archives of Pharmacal Research·Young Joon ParkHyo-Kyung Han
Nov 17, 2011·International Journal of Pharmaceutics·Yi-Dong YanHan-Gon Choi
Mar 1, 2012·Drug Development and Industrial Pharmacy·Md Akhlaquer RahmanZeenat Iqbal
Jan 18, 2013·Drug Development and Industrial Pharmacy·Greeshma V PatelSadhana J Rajput
Aug 27, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Namfa SermkaewRuedeekorn Wiwattanapatapee

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences
Urvashi GoyalGeeta Aggarwal
Journal of Controlled Release : Official Journal of the Controlled Release Society
Yong-Mei YinDae-Duk Kim
© 2021 Meta ULC. All rights reserved